Alpha DaRT224

· Alpha Tau Medical LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Alpha DaRT224, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer [NA]

See pricing